From The Washington Post: In 2017, numerous politicians, advocacy groups, and other stakeholders began to raise questions about the rising costs of prescription drugs. Under attack, the pharmaceutical industry attempted to blame pharmacy benefit managers, for-profit companies that negotiate drug price discounts on behalf of employers and insurers, which has led to major intra-industry conflict.
